Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Nafarelin Compared to Subcutaneous Triptorelin for Triggering Final Oocyte Maturation in Ovarian Stimulation: a Non-inferiority Randomised Controlled Clinical Trial

NCT06763926 is registered in ClinicalTrials.gov with Fundacion Dexeus as lead sponsor.

NCT NCT06763926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06763926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Nafarelin Compared to Subcutaneous Triptorelin for Triggering Final Oocyte Maturation in Ovarian Stimulation: a Non-inferiority Randomised Controlled Clinical Trial
Lead sponsor
Fundacion Dexeus
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 15, 2026
Completion date
January 15, 2028
Enrollment
154 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

fertility preservation